SEC Filing Details

Together with patients, physicians, scientists, and industry partners we are relentlessly focused on rewriting cancer so that a diagnosis is transformed from a foregone conclusion to a more hopeful future

SEC Filing Details

Document Details

Form
Filing Date
Apr 6, 2020
Document Date
Oct 10, 2019
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.